leukemia

mds_chemotherapy_shutterstock.jpg

UNSW medical researchers have developed a new way to predict whether patients with the blood condition myelodysplastic syndrome will respond to treatment.

18_pimanda_shutterstock.jpg

Every day, four Australians are diagnosed with myelodysplastic syndrome (MDS), but many people's resistance to the best available treatment has been poorly understood until now.